Actimmune
Links shared publicly online about this topic
ACTIMMUNE (Interferon gamma-1b) drug information from MPR
empr.com — “ACTIMMUNE (Interferon gamma-1b) drug information for Chronic granulomatous disease from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on May 27, 2011 at 4:51 am By:
MPR News: ACTIMMUNE: Monograph added. http://bit.ly/iN4VoE
Intermune Ex-CEO Harkonen Sentenced to Home Confinement in Fraud Case - Bloomberg
bloomberg.com — “W. Scott Harkonen , Intermune Inc. --™s former chief executive officer, was sentenced to six months of home confinement and fined $20,000 for his role in disseminating misleading information about the drug Actimmune for the treatment of lung disease, the Justice Department said today.” View full resource at bloomberg.com
Most Recently Shared on April 15, 2011 at 11:48 am By:
John Carroll Health Communicator
Ex-Intermune CEO Harkonen sentenced to six months of home confinement for Actimune deception. http://bloom.bg/g9EcpS
Notorious Names in Biopharma - FiercePharma
fiercepharma.com — “Scott HarkonenScott Harkonen was the CEO of InterMune when the company distributed a press release stating that lung-disease product Actimmune extended the lives of patients with a fatal lung disease known as IPF. That violates the FDA rules against” View full resource at fiercepharma.com
Most Recently Shared on April 15, 2011 at 12:48 pm By:
Intermune Ex-CEO Harkonen sentenced in Fraud Case. http://is.gd/UWx2Uv. He was in our "Notorious Names" report: http://bit.ly/dXKCUl
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
John Carroll
John Carroll is editor of FierceBiotech, where he primarily covers drug development and has for the past eight years.
-
FierceBiotech
FierceBiotech's 140, written by Managing Editor Maureen Martino. Join the largest and most active biotech news readership in the world at FierceBiotech.com.
Advertisement
